Read More 5 minute read Pharma Industry News What’s next after Zepbound? Inside Eli Lilly and Company’s pipeline beyond GLP-1 Discover which drugs Eli Lilly and Company is betting on after Zepbound, including oral GLP-1 pills and next-generation incretins that could redefine the global obesity treatment market. bySrinathDecember 8, 2025